habener glp-1 Joel Receives Breakthrough Prize in Life Sciences for Contributions to Medications Professor Joel Francis Habener -
Description
Both pre-transplant risk factors and the use of immunosuppressants, particularly corticosteroids and calcineurin inhibitors, contribute to the PTDM development [15]
[DOI] [PMC free article] [PubMed] [Google Scholar] 204.Look A.R.G., Wadden T.A., West D.S., Delahanty L., Jakicic J., Rejeski J., Williamson D., Berkowitz R.I., Kelley D.E., Tomchee C., et al
Schwartz LK, OKeefe SJ, Fujioka K, Gabe SM, Lamprecht G, Pape UF, et al
doi: 10.1007/s40262-017-0531-7
its a system that fails them
